Dataset Information


Urinary interleukin-6 as a predictor of radiographic progression in rheumatoid arthritis: A 3-year evaluation.

ABSTRACT: Previously, we demonstrated that the urine proteome signature of patients with rheumatoid arthritis (RA) reflects inflammation-related cellular processes. Here, we measured interleukin (IL)-6, IL-8, and chemokine ligand 2 (CCL2) concentrations in the urine of RA patients and prospectively investigated their role in predicting RA activity and prognosis. One hundred seventy-three RA patients and 62 non-RA controls were recruited. Urinary IL-6, CCL2, and IL-8 levels were elevated in RA patients and correlated well with disease activity. Urinary IL-6 level at presentation was an independent risk factor of radiographic progression at 1 and 3 years. High urinary IL-6 level increased the risk ratio of radiographic progression by 2.9-fold, which was comparable to high serum CRP. Moreover, combination of urinary IL-6 and serum CRP measures synergistically increased the predictability of radiographic progression. In a subgroup with normal ESR, patients with the highest tertile of urinary IL-6 were at 6.4-fold greater risk of radiographic progression. Conclusively, high urinary IL-6 level at presentation is an independent risk factor for radiographic progression of RA, reflecting disease activity. Urinary IL-6 in combination with serum CRP may be a useful parameter for estimating RA prognosis.


PROVIDER: S-EPMC5059680 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3726747 | BioStudies
2018-01-01 | S-EPMC6261241 | BioStudies
1000-01-01 | S-EPMC4710803 | BioStudies
2020-01-01 | S-EPMC7427775 | BioStudies
1000-01-01 | S-EPMC4892870 | BioStudies
2020-01-01 | S-EPMC7251027 | BioStudies
1000-01-01 | S-EPMC6262279 | BioStudies
1000-01-01 | S-EPMC5932798 | BioStudies
2015-01-01 | S-EPMC4613151 | BioStudies
2018-01-01 | S-EPMC6477524 | BioStudies